Specialists at the London start-up BenevolentAI helped identify the arthritis drug baricitinib, which is now part of a clinical trial.
Source : https://www.nytimes.com/2020/04/30/technology/coronavirus-treatment-benevolentai-baricitinib.html
Date : April 30, 2020 at 08:55PM
Tag(s) : Médias internationaux
